Laboratory of the Data Enhanced Evidence and Prvacy for Precision Medicine
(DEEP lab)

2021

• Suh J, Yuk HD, Jeong CW, Kwak C, Kim HH, Ku JH, Prognostic Impact of Preoperative Renal Insufficiency on Metastasis-Free Survival after Radical Cystectomy. Journal of Cancer, 2021; 12(24): 7320-7325. doi: 10.7150/jca.61847 

• Suh J, Han D, Ku JH, Kim HH, Kwak C, Jeong CW. Next-generation Proteomics-Based Discovery, Verification, and Validation of Urine Biomarkers for Bladder Cancer Diagnosis. Cancer Res Treat, 2021, https://doi.org/10.4143/crt.2021.642 

• Lee J, Suh J, Song C, You D, Jeong IG, Hong B, Hong JH, Kim CS, Ahn H. Association Between Sarcopenia and Survival of Patients with Organ-Confined Renal Cell Carcinoma after Radical Nephrectomy, Ann Surg Oncol. 2021 Oct 9. doi: 10.1245/s10434-021-10881-7.

• Suh J, Yuk HD, Jeong CW, Kwak C, Kim HH, Ku JH. Pyuria as a Predictive Marker of Bacillus Calmette-Guérin Unresponsiveness in Non-Muscle Invasive Bladder Cancer, J Clin Med. 2021 Aug 24;10(17):3764 

• Lee Y, Ryu J, Kang MW, Seo KH, Kim J, Suh J, Kim YC, Kim DK, Oh KW, Kim YS, Jeong CW, Lee SC, Kwak C, Kim S, Han SS, Machine learning-based prediction of acute kidney injury after nephrectomy in patients with renal cell carcinoma, Sci Rep. 2021 Aug 3;11(1):15704. doi: 10.1038/s41598-021-95019-1.

• Lee J, Suh J, Jeong CW, Kwak C, Kim HH, Ku JH. Efficacy of the Treatment of Intraperitoneal Bladder Perforation during Transurethral Resection of Bladder Tumor with the Urethral Catheter Alone: Retrospective Analysis of over 15 Years Using the Clinical Data Warehouse System, Urol Int. 2021 Jul 20:1-9. doi: 10.1159/000517332.

• Suh J, Jeong JH, Jeong CW, Kim HH, Cheol K, Ku JH, Stratifying Risk for Multiple, Recurrent, and Large (≥3 cm) Ta, G1/G2 Tumors in Non-muscle-invasive Bladder Cancer, Investig Clin Urol. 2021, Accepted not published

• Suh J, Yuk HD, Kang M, Tae BS, Ku JH, Kim HH, Cheol K, Jeong CW, The clinical impact of strict criteria for active surveillance of prostate cancer in Korean population: Results from a prospective cohort. Investig Clin Urol. 2021, epub

2020

• Suh J, Jeong CW, Choi S, Ku JH, Kim HH, Kwak C, Sharing the initial experience of pan-cancer panel analysis in high-risk renal cell carcinoma in the Korean population BMC Urol. 2020 Aug 18;20(1):125. doi: 10.1186/s12894-020-00687-2.

• Suh J, Yoo S, Park J, Cho SY, Cho MC, Son H, Jeong H. Development and validation of explainable AI-based decision-supporting tool for prostate biopsy BJU Int. 2020 Dec;126(6):694-703.  doi: 10.1111/bju.15122. Epub 2020 Aug 4

• Suh J, Yoo S, Park J, Cho MC, Jeong CW, Ku JH, Kwak C, Jeong H. Differences in risk factors for biochemical recurrence after radical prostatectomy stratified by the degree of obesity: Focused on surgical methods. Sci Rep. 2020 Jun 23;10(1):10157. doi: 10.1038/s41598-020-67237-6.

• Suh J, Jung JH, Jeong CW, Lee SE, Lee E, Ku JH, Kim HH, Kwak C. Long-term oncologic outcomes after radical prostatectomy in clinically localized prostate cancer: 10-year follow-up in Korean men. Investig Clin Urol. 2020 May;61(3):269-276. doi: 10.4111/icu.2020.61.3.269. Epub 2020 Apr 21.

• Suh J, Jeong CW, Choi S, Ku JH, Kim HH, Kim KS, Kwak C. Targeted next-generation sequencing for locally advanced prostate cancer in the Korean population, Investig Clin Urol. 2020 Mar; 61(2): 127–135. doi: 10.4111/icu.2020.61.2.127

• Park J, Suh J, Yoo S, Cho MC, Son H. Bladder wall thickness and detrusor wall thickness can help to predict the bladder outlet obstruction in men over the age of 70 years with symptomatic benign prostatic hyperplasia. Investig Clin Urol. 2020 Jan;61:e51.  

• Yoo S, Suh J, Park J, Cho MC, Son H, Jeong H. Can we improve the detection rate of prostate cancer using standard 12-core TRUS-guided prostate biopsy? Focused on the location of prostate biopsy. Cancer Med. 2020 Apr 12. doi: 10.1002/cam4.2990. Online ahead of print.

• Yoo S, Oh S, Suh J, Park J, Cho MC, Jeong H, Won S, Son H. Optimal High-Density Lipoprotein Cholesterol Level for Decreasing Benign Prostatic Hyperplasia in Men Not Taking Statin Medication: A Historical Cohort Study. Prostate. 2020 May;80(7):570-576. doi: 10.1002/pros.23970. Epub 2020 Mar 20.

• Jang G, Im YJ, Suh J, Park K. Changes in attention variables in those who treated with anticholinergic agents for nonmonosymptomatic enuresis. Investig Clin Urol. 2020;61:e15. (ePub) 2020 May

• Suh J., Yoo. S. Role of immunotherapy in Bacillus Calmette-Guérin unresponsive Non-Muscle Invasive Bladder Cancer. Transl Cancer Res. doi: 10.21037/tcr-20-758

• Suh J., Oh SJ, Cho SY. Comprehensive review of effective application of questionnaires for clinical research on lower urinary tract symptoms with translation and cultural adaptation to the Korean language. Int Neurourol J. doi: 10.5213/inj.2040074.037

2019

• Suh J, JH Jung, CW Jeong, C Kwak, HH Kim, JH Ku, Clinical significance of pre-treated Neutrophil-Lymphocyte Ratio in the management of urothelial carcinoma: A Systemic Review and Meta-Analysis. Frontiers in Oncology, 2019 Dec 16;9:1365. 

• Suh J, Moon KC, Jung JH, Lee J, Song WH, Kang YJ, Jeong CW, Kwak C, Kim HH, Ku JH, BCG instillation versus radical cystectomy for high-risk NMIBC with squamous/glandular histologic variants. Sci Rep. 2019 Oct 24;9(1):15268. doi: 10.1038/s41598-019-51889-0 

• Suh J, Ku JH. To achieve the best performance of transurethral resection of bladder tumor: implication of surgical checklist. Transl Androl Urol. 2019 Mar;8(Suppl 1):S85-S87. doi: 10.21037/tau.2019.01.06.

• Yoo S, Suh J, Park J, Cho MC, Son H, Jeong H. Proportion of cores with the highest Gleason grade group among positive cores on prostate biopsy: does this affect the probability of upgrading or downgrading? Scand J Urol. 2019 Nov 1:1-6. doi: 10.1080/21681805.2019.1681506.

• Jeong CW, Suh J, Yuk HD, Tae BS, Kim M, Keam B, Kim JH, Kim SY, Cho JY, Kim SH, Moon KC, Cheon GJ, Ku JH, Kim HH, Kwak C. Establishment of the Seoul National University Prospectively Enrolled Registry for Genitourinary Cancer (SUPER-GUC): A prospective, multidisciplinary, bio-bank linked cohort and research platform. Investig Clin Urol. 2019 Jul;60(4):235-243. doi: 10.4111/icu.2019.60.4.235. 

• Suh J. Jeong CW. Comprehensive Molecular Characterization of Urological Malignancies: Literature Review of Landmark Studies. Korean journal of urological oncology 2019; 17(3): 125-135. DOI: https://doi.org/10.22465/kjuo.2019.17.3.125

• Lee SH, Suh J, Kim HS, Lee YJ, Lee SR, Kim KH, Jeong CW. Prevalence and management status of urologic diseases in geriatric hospitals in South Korea: A field research. Investig Clin Urol. 2017 Jan;58(1):70-76. doi: 10.4111/icu.2017.58.1. 70.